Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Merten Hommann"'
Publikováno v:
Die Pathologie.
Autor:
Dieter Hörsch, Merten Hommann, Daniel Kaemmerer, Susanne Sehner, Matthias Twrznik, Harshad R. Kulkarni, Richard P. Baum
Publikováno v:
Annals of Surgery. 274:e45-e53
OBJECTIVE The aim of the study was to compare impact on survival after resection of primary tumors (PTs) after peptide receptor radionuclide therapy (PRRT). BACKGROUND PRRT is a highly effective therapeutic option to treat locally advanced or metasta
Autor:
Arthur Jochems, Dieter Hörsch, Karin Niepsch, Philippe Lambin, Merten Hommann, Daniel Kaemmerer, Franz C Robiller, Richard P. Baum, Vikas Prasad, Harshad R. Kulkarni, Aviral Singh, Holger Franz, Dirk Mueller
Publikováno v:
Oncotarget, 9(24), 16932-16950. Impact Journals LLC
Oncotarget
Oncotarget
// Richard P. Baum 1 , Harshad R. Kulkarni 1 , Aviral Singh 1 , Daniel Kaemmerer 2 , Dirk Mueller 1 , Vikas Prasad 3 , Merten Hommann 2 , Franz C. Robiller 4 , Karin Niepsch 1 , Holger Franz 5 , Arthur Jochems 6 , Philippe Lambin 6, 7 and Dieter Hors
Publikováno v:
Clinical Nuclear Medicine. 46:409-410
The presence of primary neuroendocrine tumors in the liver is still a matter of controversy. We present a case of a somatostatin-receptor-positive mass of the liver in the 68Ga-DOTATOC PET/CT. No other primary tumor was found after conventional imagi
Autor:
Matthias Anthuber, Jörg Köninger, Thomas Klier, Katharina Feilhauer, Ulrich F. Wellner, Tobias Keck, Visceral Surgery, Merten Hommann, Ulrich Mansmann, Hryhoriy Lapshyn, Luisa Peter, Hans-Jörg Krämling, Detlef K. Bartsch, Natascha C Nüssler, Ulrich T. Hopt, Hubert Preissinger-Heinzel, Ioannis Mintziras, Uwe A. Wittel, Bernd Geissler
Publikováno v:
International Journal of Colorectal Disease. 32:273-280
The aim of this study was to assess intraoperative, postoperative, and oncologic outcome in patients undergoing laparoscopic distal pancreatectomy (LDP) versus open distal pancreatectomy (ODP) for benign and malignant lesions of the pancreas. Data fr
Autor:
Ekaterina Petrova, Hryhoriy Lapshyn, Dirk Bausch, Jan D'Haese, Jens Werner, Thomas Klier, Natascha C. Nüssler, Jochen Gaedcke, Michael Ghadimi, Waldemar Uhl, Orlin Belyaev, Olga Kantor, Marshall Baker, Tobias Keck, Ulrich F. Wellner, Carsten Crones, Frank Klammer, Matthias Anthuber, Merten Hommann, Klaus Prenzel, Johann Pratschke, Eric P.M. Lorenz, Jörg C. Kalff, Ute Tröbs, Helmut Witzigmann, Hans-Jörg Krämling, Albrecht Stier, Robert Grützmann, Marco Niedergethmann, Matthias Schwarzbach, Wolf Otto Bechstein, Thomas Kraus, Stefan Fichtner-Feigl, Michael Kindler, Thomas Manger, Winfried Padberg, Karl-Jürgen Oldhafer, Ansgar Michael Chromik, Nurettin Albayrak, Matthias Glanemann, Christian Mönch, Hans-Bernd Reith, Christiane Bruns, Anton J. Kroesen, Sven Eisold, Ullrich Fleck, Stefan Post, Detlef Bartsch, Carsten Gutt, Natascha Nüssler, Helmut Friess, Norbert Senninger, Hubert Stein, Franz-Josef Schumacher, Dietmar Lorenz, Pompiliu Piso, Ernst Klar, Jörg-Peter Ritz, Jörg Köninger, Norbert Runkel, Elke Wagler, Christoph Jacobi, Stefan Farkas, Mark Jäger, Christoph-Thomas Germer
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 19(1)
Background Postoperative pancreatic fistula (POPF) is a major factor for morbidity and mortality after pancreatic resection. Risk stratification for POPF is important for adjustment of treatment, selection of target groups in trials and quality asses
Autor:
Shereen Ezzat, Anil K. Rustgi, Stuart L. Schreiber, Kay Washington, Arul M. Chinnaiyan, Andrew L. Kung, Elena V. Komissarova, Charles Karan, Beatrice S. Knudsen, Diane Reidy-Lagunes, Daniel Diolaiti, Zhong Li, Irvin M. Modlin, Roberto Bergamaschi, Andrea Frilling, Jakob Regberg, David C. Metz, Filemon S. Dela Cruz, Deepti Dhall, Douglas A. Fraker, Emer Leahy, Ülo Langel, Ronald Realubit, Laura H. Tang, Stefano Serra, Afshin Ghavami, Prem S. Subramaniam, Antonia R. Sepulveda, Tony Detre, Lisa Bodei, Jeffrey W. Milsom, Xiaopu Yuan, Mark Kidd, Andrea Califano, Daniel Kaemmerer, Kyoung Mi Kim, Young Suk Park, Mariano J. Alvarez, Paul A. Clemons, Elizabeth A. Hagan, Robert E. Roses, Helen Remotti, Jeeyun Lee, Hai Li, Roswitha Pfragner, Massimo Barberis, Merten Hommann, Virginia A. LiVolsi, Allison R. Rainey, Michelle K. Kim, Adina Grunn, Gabrielle E. Rieckhof, Chanjuan Shi, Bertram Wiedenmann, Hee C. Kim, Dirk Jaeger, Lakshmi P. Kunju, Mahalaxmi Aburi
Publikováno v:
Nat Genet
We introduce and validate a new precision oncology framework for the systematic prioritization of drugs targeting mechanistic tumor dependencies in individual patients. Compounds are prioritized on the basis of their ability to invert the concerted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d09dc99068d6a36407f03e9aa66176
http://hdl.handle.net/10044/1/60492
http://hdl.handle.net/10044/1/60492
Autor:
Bence Sipos, Jörg Sänger, Tina Träger, Maike Hoffmeister, Amelie Lupp, Merten Hommann, Daniel Kaemmerer, Stefan Schulz
Publikováno v:
Oncotarget
// Daniel Kaemmerer 1 , Tina Trager 1, 2 , Maike Hoffmeister 3 , Bence Sipos 3 , Merten Hommann 1 , Jorg Sanger 4 , Stefan Schulz 2 , Amelie Lupp 2 1 Department of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka, Germany 2 Department
Autor:
Richard P. Baum, Vikas Prasad, Merten Hommann, Elisa Specht, Stefan Schulz, Amelie Lupp, Elke K. Fischer, Ralph M. Wirtz, Daniel Kaemmerer, Jörg Sänger
Publikováno v:
Pancreas. 44:648-654
OBJECTIVE Gallium 68 somatostatin receptor (SSTR) positron emission tomography/computed tomography (PET/CT) is one of the most sensitive imaging methods for pancreatic neuroendocrine tumors. The aim of the study was to correlate the receptor density
Publikováno v:
Clinical Nuclear Medicine. 39:713-716
Ga somatostatin receptor PET/CT, currently the most sensitive imaging modality for well-differentiated neuroendocrine tumors, is based on the molecular imaging of somatostatin receptors (SSTRs) that are expressed in different tumor entities such as n